Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$67,883,350
-$11,399,547 QoQ
Shares Held
2,819,076
-0.2% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROYAL LONDON ASSET MANAGEMENT LTD holds $4,029,879,846 across 10 Drug Manufacturers - General names. PFE ranks #8 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
10,161,026 | $1,926,733,750 | |
| 2 | LLY |
ELI LILLY & Co
|
645,864 | $774,668,722 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,987,037 | $383,834,254 | |
| 4 | ABBV |
AbbVie Inc.
|
1,342,483 | $337,822,422 | |
| 5 | JNJ |
Johnson & Johnson
|
1,189,474 | $302,090,711 | |
| 6 | AMGN |
Amgen Inc
|
280,510 | $101,578,281 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
551,867 | $69,722,876 | |
| 8 | PFE |
Pfizer Inc
This page
|
2,819,076 | $67,883,350 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67,883,350 | 2,819,076 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $79,282,897 | 2,823,465 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $69,692,585 | 2,798,899 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $71,855,128 | 2,820,060 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $63,996,799 | 2,640,132 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $68,091,063 | 2,687,098 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $65,292,346 | 2,461,076 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $69,261,754 | 2,393,288 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $65,182,235 | 2,329,601 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $65,170,292 | 2,348,479 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $67,701,009 | 2,351,546 | Shares | Sole | 2024-03-01 | |
| 2023-09-30 | $76,732,492 | 2,313,310 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $80,700,951 | 2,200,135 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $82,193,354 | 2,014,543 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $102,159,186 | 1,993,739 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $83,909,975 | 1,917,504 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $103,984,104 | 1,983,294 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $101,902,152 | 1,968,363 | Shares | Sole | 2022-09-06 | |
| 2021-12-31 | $111,746,574 | 1,892,406 | Shares | Sole | 2022-10-18 | |
| 2021-09-30 | $84,398,307 | 1,962,295 | Shares | Sole | 2022-10-18 | |
| 2021-06-30 | $78,867,143 | 2,013,972 | Shares | Sole | 2022-10-18 | |
| 2021-03-31 | $74,493,046 | 2,056,115 | Shares | Sole | 2022-10-17 | |
| 2020-12-31 | $74,739,171 | 2,030,404 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $77,754,084 | 2,118,642 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $69,526,746 | 2,126,198 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $71,576,681 | 2,192,916 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||